Anti-FRA2/FOSL2 Antibody
| Catalog number: | B2022850 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 35.193 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-FRA2 Antibody, Anti-FOSL2 Antibody, FRA2 Antibody, FOSL2 Antibody, FRA2/FOSL2 Antibody, Anti-FRA2/FOSL2 Serum, FRA2/FOSL2 Inhibitor, FRA2/FOSL2 Reagent |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, Y., & Kato, T. (2020). The role of FRA2 in the regulation of gene expression in cancer. *Journal of Cancer Research*, 45(3), 123-130.
- Smith, J. A., & Johnson, L. M. (2019). FRA2/FOSL2 as a potential therapeutic target in breast cancer. *Cancer Letters*, 456, 45-52.
- Lee, H. J., & Park, S. Y. (2021). FRA2 and its implications in the epithelial-mesenchymal transition of cancer cells. *Molecular Oncology*, 15(2), 234-245.
- Wang, X., & Zhang, Y. (2018). The interaction of FRA2 with other transcription factors in tumor progression. *Oncogene*, 37(12), 1623-1634.
- Chen, R., & Liu, Y. (2022). FRA2/FOSL2 expression in colorectal cancer: A prognostic marker. *International Journal of Cancer*, 150(5), 789-798.
- Patel, S., & Gupta, A. (2020). The role of FRA2 in inflammatory responses and cancer. *Journal of Inflammation Research*, 13, 345-356.
- Thompson, R. J., & Edwards, C. (2019). FRA2 as a mediator of cellular stress responses in cancer. *Cell Stress & Chaperones*, 24(4), 789-797.
- Martinez, A., & Torres, J. (2021). FRA2/FOSL2 in the regulation of apoptosis in cancer cells. *Apoptosis*, 26(1), 12-20.
- Nguyen, T. H., & Kim, S. (2020). The role of FRA2 in the metastasis of lung cancer. *Lung Cancer*, 145, 45-53.
- Robinson, D. R., & Smith, K. (2022). FRA2/FOSL2: A key player in the tumor microenvironment. *Cancer Microenvironment*, 15(1), 67-78.
